Could You Have Seen The Run In Guardant Health Stock Coming?
For questions about this article or underlying research, email help@trefis.com. Guardant Health (GH) stock gained 60.6% in the twelve months to November 10, 2026, on top of a 131.8% rise in the six months before that. By the end of that run, Shield, the company’s blood test for colorectal cancer screening, was its fastest-growing business. […]